EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS

Klara Welcker iD, Martin A Schneider, Tim Reese, Andrea Ehrenfeld, Hauke Weilert, Axel Stang iD, Peter Wohlmuth iD, Mia-Maria Warnke, Carolin Reiner iD, Thomas von Hahn, Karl J Oldhafer, Andreas H Mahnken und 1 weitere

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0307937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Klara Welcker und 12 weiteren Autor:innen. Beteiligte Einrichtung: Radiology and Neuroradiology, Asklepios Hospital Barmbek, Hamburg, Germany. Hauptthemen laut MEDLINE: Hepatectomy, Portal Vein, Liver Neoplasms, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Modern liver surgery has improved the percentage of potentially resectable malignant tumors. However, if the future liver remnant is small, patients remain at risk of developing postoperative liver failure. Thus, the future liver remnant must be increased, while at the same time, the primary tumor may have to be controlled by chemotherapy. To address this conflict, we retrospectively analyzed the changes in hypertrophy before and after Associating Liver Partition with Portal vein ligation for Staged hepatectomy (ALPPS) or Portal Vein Embolization (PVE), with or without parallel systemic chemotherapy. Materials and Methods We retrospectively analysed 172 patients (54 female and 118 male), treated with ALPPS in 90 patients (median age 61 years [Q1, Q3: 52,71]) and with PVE in 82 patients (median age 66 years [Q1, Q3: 56,73]). The median control interval was 4.9 [Q1, Q3: 4.0, 6.0] weeks after the PVE, and 2.6 [Q1, Q3: 1.6, 5.8] weeks after ALPPS step 1.

Results

The overall kinetic growth rate (median) for the entire group was 0.02 (2%) per week. When systemic chemotherapy was administered prior to intervention, the kinetic growth rate of these treated patients (vs. untreated) exhibited a median of 0.020 [Q1, Q3: 0.011, 0.067] compared to 0.024 [Q1, Q3: 0.013, 0.041] (p = 0.949). When chemotherapy was administered after the PVE/ ALPPS treatment, the kinetic growth rate declined from a median of 0.025 [Q1, Q3: 0.013, 0.053] to 0.011 [Q1, Q3: 0.007, 0.021] (p = 0.005). Subgroup analysis showed statistically significant effects only in the PVE group (median ALPPS -45% (p = 0.157), PVE -47% (p = 0.005)).

Conclusion

This retrospective analysis indicated that systemic chemotherapy given after PVE/ the first step of the ALPPS procedure, i.e., the growth phase, has a negative effect on the kinetic growth rate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatectomyPortal VeinLiver NeoplasmsLiverEmbolization, TherapeuticHumansMaleFemaleAgedMiddle AgedRetrospective StudiesLigationKinetics

Autor:innen und Institutionen

  • Radiology and Neuroradiology, Asklepios Hospital Barmbek, Hamburg, Germany.
  • Department of Surgery, Division of Liver-, Bileduct- and Pancreatic Surgery, Asklepios Hospital Barmbek, Hamburg, Germany.
  • Gastroenterology, Hepatology and interventional Endoscopy, Asklepios Hospital Barmbek, Hamburg, Germany.
  • Oncology, Asklepios Hospital Barmbek, Hamburg, Germany.
  • Clinic for Diagnostic and Interventional Radiology, Philipps University and University Clinic Marburg, Marburg, Germany.
  • Medical Faculty, Semmelweis University Budapest, Hamburg, Germany.

ORCID-Profile: Klara Welcker, Axel Stang, Peter Wohlmuth, Carolin Reiner

Zitieren

APA

Welcker, K., Schneider, M. A., Reese, T., Ehrenfeld, A., Weilert, H., Stang, A., Wohlmuth, P., Warnke, M. M., Reiner, C., von Hahn, T., Oldhafer, K. J., Mahnken, A. H., & Brüning, R. (2025). Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS. PLOS ONE. https://doi.org/10.1371/journal.pone.0307937

Vancouver

Welcker K, Schneider MA, Reese T, Ehrenfeld A, Weilert H, Stang A, et al. Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS. PLOS ONE. 2025. doi:10.1371/journal.pone.0307937

BibTeX
@article{Welcker2025,
  author = {Welcker, Klara and Schneider, Martin A and Reese, Tim and Ehrenfeld, Andrea and Weilert, Hauke and Stang, Axel and Wohlmuth, Peter and Warnke, Mia-Maria and Reiner, Carolin and von Hahn, Thomas and Oldhafer, Karl J and Mahnken, Andreas H and Brüning, Roland},
  title = {Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0307937}
}
Kostenlos starten →